Scotia Capital’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Scotia Capital’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-14,949	Closed	-$655K	–	906
2021 Q4	$655K	Buy	14,949 +100	+0.7%	+$4.73K	﹤0.01%	586
2021 Q3	$753K	Sell	14,849 -367	-2%	-$19.1K	0.01%	557
2021 Q2	$792K	Sell	15,216 -3,885	-20%	-$182K	0.01%	557
2021 Q1	$873K	Buy	19,101 +490	+3%	+$23.9K	0.01%	519
2020 Q4	$855K	Buy	18,611 +644	+4%	+$27.8K	0.01%	471
2020 Q3	$700K	Buy	+17,967	New	+$691K	0.01%	448

Other funds holding IDNA

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

Scotia Capital's IDNA Position: Q1 2022 in Review

Scotia Capital sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q1 2022, closing a stake of 14,949 shares — an estimated $655K sold.

Scotia Capital first reported a position in IDNA in Q3 2020 and held it in 6 quarters. The position peaked at $873K in Q1 2021. 86 funds tracked by Wall St. Rank hold IDNA as of Q1 2022.

Scotia Capital reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q1 2022 after selling out during the quarter.
Scotia Capital sold 14,949 iShares Genomics Immunology and Healthcare ETF shares in Q1 2022, an estimated $655K.
Scotia Capital first reported a position in iShares Genomics Immunology and Healthcare ETF in Q3 2020 and held it in 6 quarters.
Scotia Capital's iShares Genomics Immunology and Healthcare ETF position peaked at $873K in Q1 2021.
86 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q1 2022.

Based on Scotia Capital's 13F filing for Q1 2022, filed 9 May 2022.